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Abstract
The effects of olive oil phenolic compounds (PCs) on HDL proteome, with respect to new
aspects of cardioprotective properties, are still unknown. The aim of this study was to as-
sess the impact on the HDL protein cargo of the intake of virgin olive oil (VOO) and two func-
tional VOOs, enriched with their own PCs (FVOO) or complemented with thyme PCs
(FVOOT), in hypercholesterolemic subjects. Eligible volunteers were recruited from the
IMIM-Hospital del Mar Medical Research Institute (Spain) from April 2012 to September
2012. Thirty-three hypercholesterolemic participants (total cholesterol >200mg/dL; 19 men
and 14 women; aged 35 to 80 years) were randomized in the double-blind, controlled,
cross-over VOHF clinical trial. The subjects received for 3 weeks 25 mL/day of: VOO,
FVOO, or FVOOT. Using a quantitative proteomics approach, 127 HDL-associated proteins
were identified. Among these, 15 were commonly differently expressed after the three VOO
interventions compared to baseline, with specific changes observed for each intervention.
The 15 common proteins were mainly involved in the following pathways: LXR/RXR activa-
tion, acute phase response, and atherosclerosis. The three VOOs were well tolerated by all
participants. Consumption of VOO, or phenol-enriched VOOs, has an impact on the HDL
proteome in a cardioprotective mode by up-regulating proteins related to cholesterol ho-
meostasis, protection against oxidation and blood coagulation while down-regulating
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Introduction
Olive oil (OO) is a food item typical of the Mediterranean diet, and several studies have revealed
that it has a unique phenolic profile with specific biological properties. Results from the Europe-
an EUROLIVE study [1] showed that an increase in plasma HDL cholesterol, and a decrease of
LDL oxidation, took place in a direct relationship with the phenolic compound (PC) content of
the OO administered. These findings provided evidence to recommend the use of PC-rich OO,
i.e. virgin olive oil (VOO), in order to achieve beneficial effects improving lipid profile and con-
ferring protection from oxidative damage. The difference of PC content between OO and VOO
is due to the elaboration process (www.internationaloliveoil.org). To date, studies have been fo-
cused on hydroxytyrosol because it has been reported as being the most biologically active PC in
OO [2]. In fact, the European Food Safety Authority considers that the health claim may be
used only for OO which contains at least 5mg of hydroxytyrosol and its derivatives per 20g of
OO [2]. As the phenolic concentration in most of the VOOs available on the market is too low
to provide this daily amount of hydroxytyrosol, the enrichment of VOO with its own PCs could
be a possible approach to assure the consumption without increasing caloric intake [3,4]. Fur-
thermore, the enrichment of VOO with its own PCs could lead to a bitter organoleptic taste
caused by the presence of secoiridoids (hydroxytyrosol and its derivatives; oleruopein and lig-
stroside aglycones) [5]. Moreover, in terms of biological effects, synergistic effects with stronger
improvements have been reported when different PCs are combined in comparison to single
treatments [6]. For these reasons, the enrichment of a VOO by complementing its own phenols
with PCs of aromatic herbs has been done in order to improve its nutritional profile and organ-
oleptic characteristics. Thyme could enhance perfectly these features of a phenol-enriched VOO
because it is one of the richest sources of flavonoids, such as naringenin, eriodictyol and api-
genin and phenolic acids such as rosmarinic acid, ferulic acid and caffeic acid [7,8].
Approximately one hundred different proteins, not considered to be apolipoproteins
(APO), have been identified as being associated with the HDL particle [9] and linked to its car-
dioprotective properties. Analysis of the HDL protein cargo is, however, still in its early stages,
and data concerning the HDL proteome as a biomarker for disease or functionality are limited.
Moreover, studies with respect to the impact of dietary interventions on the HDL proteome are
scarce [10], and the effects of OO PCs on the complex structure of the HDL protein cargo have
not yet been evaluated.
In this context, we hypothesized that sustained consumption of PCs from VOO, or func-
tional phenol-enriched VOO, could modify the HDL proteome, which in turn could be related
to their cardioprotective benefits. The objective of the current study was to assess the impact
on the HDL protein cargo of a dietary intervention supplemented with a VOO or two different
functional VOOs enriched with their own PCs (hydroxytyrosol and its derivatives; oleuropein
and ligstroside aglycones) or complemented with thyme PCs (flavonoids, monoterpens, and
phenolic acids), in hypercholesterolemic subjects from the VOHF study.
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Materials and Methods
Subjects and study design
The VOHF study aimed at assessing whether functional VOOs, enriched with their own PCs
or with them plus complementary phenols from thyme, could have a nutraceutical effect on
HDL lipoprotein functionality. The present clinical trial was conducted in accordance with the
Helsinki Declaration and the Good Clinical Practice for Trials on Medical Products in the Eu-
ropean Community. All participants provided written informed consent, and the local institu-
tional ethics committees approved the protocol (Comité Ético de Investigación Clínica del
Instituto Municipal de Asistencia Sanitaria; CEIC-IMAS 2009/3347/I) registered with the In-
ternational Standard Randomized Controlled Trial register (www.internationaloliveoil.org;
ISRCTN77500181). This trial was conducted according to extended CONSORT 2010
guidelines.
The VOHF study was a double-blind, randomized, controlled, crossover clinical trial with
33 hypercholesterolemic volunteers (total cholesterol>200 mg/dL; 19 men and 14 women),
aged 35 to 80 year. Exclusion criteria included the following: BMI>35 Kg/m2, smokers, ath-
letes with high physical activity (>3000 Kcal/day), diabetes, multiple allergies, intestinal dis-
eases, or any other disease or condition that could worsen compliance. The study was
conducted at IMIM- Hospital del Mar Medical Research Institute (Spain) from April 2012 to
September 2012. The participants’ flow chart is described in Fig 1.
Subjects were randomly allocated to one of 3 sequences of administration of 25 mL/day of
raw: a) VOO; 80 mg of PCs/kg oil, b) functional VOO enriched with its own PCs (FVOO; 500
mg of PCs/kg oil), and c) functional VOO enriched with its own PCs plus complementary phe-
nols from thyme (FVOOT; 500 mg of PCs/kg; 50% of OO PCs and 50% of thyme PCs) (Se-
quence 1: FVOO, FVOOT and VOO, Sequence 2: FVOOT, VOO and FVOO, Sequence 3:
VOO, FVOO and FVOOT) (Fig 2). The random allocation sequence was generated by a statis-
tician, participant enrolment was carried out by a researcher, and participants’ assignment to
interventions according to the random sequence was done by a physician. Due to the fact that
all participants received each one of the three VOOs, restrictions such as blocking were unnec-
essary. Intervention periods were of 3 weeks and VOOs were consumed daily distributed
among meals. There was a 2-week washout period prior to VOO interventions during which a
common OO was consumed. A 3-day dietary record was administered to the participants at
baseline and before and after each intervention-period. A nutritionist personally advised par-
ticipants to replace all types of habitually consumed raw fats with the olive oils, and to limit
their PC-rich foods consumption during the clinical trial. A set of portable containers with the
corresponding 25 mL of VOO for each day of consumption were delivered to the participants
at the beginning of each VOO administration period. The participants were instructed to re-
turn the containers to the center after the corresponding VOO consumption period in order to
register the amount consumed. Moreover, the metabolites hydroxytyrosol sulfate, hydroxytyr-
osol acetate sulfate, thymol sulfate and hydroxyphenylpropionic acid sulfate were measured in
24-h urine in order to monitor the compliance after the intake of two phenol-enriched VOO
[11]. Furthermore, concentration of the different phenolic metabolites was determined in the
HDL fractions of the all participants. The concentrations of the metabolites present in the
HDL pools used for proteomics analyses (as described below) are shown in S1 Table.
Preparation and characterization of VOOs
The procedure to obtain the phenolic extracts and the enriched oils has been previously de-
scribed [7]. Briefly, VOO with a low phenolic content was used as a control condition in the
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intervention and as an enrichment matrix for the preparation of the two phenol-enriched olive
oils. FVOO was enriched with its own PCs by adding a phenol extract obtained from freeze-
dried olive cake collected from a commercial olive mill in the olive-growing area of Les Garri-
gues (Lleida, Catalonia, Spain). FVOOT was enriched with its own PC (50%) and comple-
mented with thyme PC (50%) using a phenol extract made up of a mixture of olive cake and
commercially available dried thyme (Thymus zyguis). The phenolic extracts used for enrich-
ment were obtained in the laboratory using an accelerated solvent extractor (ASE 100 Dionex,
Sunnyvale, CA). S2 Table shows the PCs, the fat soluble micronutrients, and the fatty acid daily
intake with 25mL of VOO, FVOO, and FVOOT. The phenolic profile of the VOO was ana-
lyzed by high-performance liquid chromatography coupled to tandem mass spectrometry
(HPLC/MS/MS) using the method previously described [7]. Tocopherols and fatty acids in
VOO were analyzed following the procedure described by Morelló et al. (2004) [12] and the ca-
rotenoid content was analyzed as described before by Criado et al. (2008) [13].
Fig 1. Participants Flow-chart based on post-interventions of HDL proteomics variable. Sequence 1: FVOO, FVOOT and VOO; Sequence 2: FVOOT,
VOO and FVOO; Sequence 3: VOO, FVOO and FVOOT.
doi:10.1371/journal.pone.0129160.g001
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Sample size and power analysis
The sample size of 30 individuals allows at least 80% power to detect a statistically significant
difference among three groups of 3 mg/dL of HDL-C and a standard deviation of 1.9, using an
ANOVA test and assuming a dropout rate of 15% and a Type I error of 0.05.
Collection of blood samples
Fasting blood samples were taken from 33 participants before the first washout period (first
visit-baseline) and after each VOO intervention period (visits 3, 5, and 7), through a catheter
in an antecubital vein (Fig 2). Blood was collected in Vacutainer tubes with K2EDTA antico-
agulant. Blood samples were centrifuged at 1 500 xg for 15 minutes and 2.8 mL of plasma
were finally recovered. Protease Inhibitor Cocktail (PIC; Sigma-Aldrich, Tres Cantos, Spain)
was added to plasma at a concentration 1/100 (1 μL of PIC for 100 μL of plasma). All
samples were stored at -80°C until processing. A total of 123 plasma samples were used for
proteomic analyses (33 participants per 4 visits minus 9 missing). See proteomic study flow
chart (Fig 3).
Human plasma HDL isolation
The HDL fraction (d = 1.036–1.21 g/mL) from each sample was isolated from 2.5 mL of plas-
ma by sequential density ultracentrifugation in two steps using sodium bromide (NaBr;
Sigma-Aldrich, Tres Cantos, Spain), as previously described by Havel RJ, et al. [14]. Sequential
ultracentrifugation continues to be the procedure most commonly used for isolation of HDL
in proteomic studies. To date, nearly all proteomic studies of HDL have utilized density gradi-
ent ultracentrifugation based on methods for the isolation of HDL from human plasma
[15,16]. Briefly, the VLDL, IDL, and LDL, were removed by ultracentrifugation at 140 000 xg
for 21 h at 10°C after adjustment of the plasma density to 1.063mg/mL with NaBr. The HDL
fraction was obtained by adjusting the infranatant density to 1.21 mg/mL with NaBr prior to
Fig 2. Experimental protocol for the intervention study. VOO: Virgin Olive Oil; FVOO: Functional Virgin
Olive Oil enriched with its own PC; FVOOT: Functional Virgin Olive Oil enriched with its own PC plus
complementary phenols from thyme. Blood collection for proteomic analysis: Visit 1, baseline; Visit 3, post-
first intervention; Visit 5, post-second intervention; Visit 7, post-third intervention.
doi:10.1371/journal.pone.0129160.g002
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Fig 3. Proteomic study flow chart. S1: Sequence 1; S2: Sequence 2; S3: Sequence 3; HDL: P.: Pool; SCX:
Strong Cation Exchange. Visits with n lower than 11 was due to loss of participants for the following reasons:
dropout, did not participate in all interventions, did all the interventions but not all the tests, or sample loss
during laboratory processing.
doi:10.1371/journal.pone.0129160.g003
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ultracentrifugation at 140 000 xg for 40 h at 10°C. 2 mL of HDL fraction were recovered and
later stored at -80°C.
HDL biochemical characterization
Apo A-I, Apo A-II and Apo B-100 were determined in each volunteer HDL fraction using
immuno-turbidimetry assays (Horiba, Montpellier, France) in an autoanalyzer Cobas-Mira
Plus (Roche Diagnostic System, Madrid, Spain). Total Cholesterol, Free Cholesterol, Phospho-
lipids and Triglycerides were determined by enzymatic colorimetric techniques (Spinreact, Gi-
rona, Spain) also in the autoanalyzer Cobas-Mira Plus. Total protein was quantified in HDL
fractions by the Bradford method (BioRad, Hercules, CA, USA). HDL fraction purity was as-
sessed through the measurement of Apo B-100, almost all samples exhibited concentrations
below the limit of detection (2 mg/dL).
Proteomic sample preparation and quantitative analysis
For the proteomics studies (detailed in Supporting Information Data) the 123 isolated HDL
samples were reduced to ten pools: 1 from first visit- baseline, 3 after third visit, 3 after fifth
visit, and 3 after seventh visit (Fig 3). The pools were then dialyzed and delipidated by metha-
nol/diethyl ether extraction, followed by a trichloroacetic acid/acetone protein precipitation be-
fore an in-solution tryptic digestion. Samples were subjected to an iTRAQ labeling for
quantitative analysis, the resulting labeled peptides were separated according to their isoelectric
point on an OffGel fractionator. Finally, two aliquots of the sample were analyzed by two dif-
ferent MS techniques, nano LC-MALDI MS/MS and nano LC-ORBITRAP-ESI MS/MS, to
provide reliability and robustness (Fig 3). The files generated with the two mass spectrometers
were combined in order to identify the HDL-associated proteins. The final identified proteins
were required to present more than one peptide-spectrum match (PSM), or to have a mini-
mum confidence score> 30% and coverage > 10%, in order to ensure accuracy in the assign-
ment of protein identifications. In addition, intracellular and cell surface proteins were
removed as being possible contaminants. In order to identify the differentially expressed pro-
teins after interventions with respect to first visit- baseline, only samples analyzed by nano
LC-ORBITRAP-ESI MS/MS were used due to the precision of this method. Relative expression
levels were calculated for each protein as a ratio by Proteome Discoverer; biological replicates
from the three iTRAQ sequences were then combined in an Excel spreadsheet and the mean of
the ratios of all proteins calculated. Proteins with a differential expression of at least 0.8-fold
change, or 1.3-fold change relative to baseline, were considered differentially expressed. In ad-
dition, a cut-off inferior to 0.5, or superior to 1.5, was applied to establish the most relevant
protein expression changes observed after each intervention, defined as stronger effects. A
detailed description of the methods and analysis is provided in the online S1 Supporting
Information.
Clustering and pathway analysis
Various bioinformatics tool were employed for the biological interpretation of the results. Pro-
teins are referred to by their gene encode symbol.
Hierarchical clustering of protein expression data to investigate overall similarities of the
proteome samples and identify the main biological functions involved was performed in web-
tool STRING 9.1 (http://string-db-org). Ingenuity Pathway analysis (IPA; Ingenuity System
Inc., Redwook, CA, USA, www.ingenuity.com) was used to analyze canonical pathways and
protein networks involving the differentially expressed proteins for biological interpretation
(Fig 3). Significance levels were assessed with Fisher’s exact tests (p<0.01). The differentially
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expressed proteins were overlaid with IPA-curated canonical pathways to explore possible met-
abolic and cell signaling pathways that were over- or under-represented by the experimentally
determined genes. Specifically, we analyzed the proteins that overlapped the three VOO inter-
ventions in order to investigate potential common OO PCs mechanisms. In addition, possible
connections between mapped genes were evaluated and graphical networks were algorithmi-
cally generated. Nodes representing genes and gene products were linked by biological relation-
ships. Networks were ranked by a score that defines the probability of a collection of nodes
being equal to or greater than the number in a network achieved by chance alone.
Immunodetection assays
Apo A-I and Apo A-II, in the HDL pools, were determined using immunoturbidimetry assays
(Horiba, Montpellier, France) in an autoanalyzer Cobas-Mira Plus (Roche Diagnostic System,
Madrid, Spain). The quantification of haptoglobin and clusterin was performed using two
commercial ELISA assays following manufacter’s instructions; the AssayMax Haptoglobin
ELISA kit (AssayPro, MO, USA) and the Human Clusterin ELISA Kit (RayBiotech, GA,
USA), respectively.
Statistical analysis of biochemical data
The Kolmogorov-Smirnov test was used to verify the distributions of the variables. A paired
Student’s t-test was employed for the comparison of paired and normally distributed variables.
Wilcoxon signed-rank test was used for the comparison of paired and non-normally distribut-
ed variables. The level of statistical significance was set at p< 0.05. The possible interaction be-
tween the treatments and the treatment sequence (carryover effect) was assessed testing the
period by treatment interaction-effect under a linear mixed model. All statistical analyses were
performed with Statistical Package for the Social Sciences (SPSS) for Windows (20.0 version;
IBM corp., Armonk, NY, USA).
Results
Participants’ characteristics
Table 1 summarizes the baseline characteristics of the study participants, significant differences
were not observed among groups. No changes were observed in the main nutrients and medi-
cation intake throughout the study. The three VOOs were well tolerated by all participants and
no adverse events were reported.
Biochemical characterization of HDL fractions
Biochemical characterization of HDL and also Apo A-I and HDL-c plasma levels segregated
according to VOO intervention sequence are described in detail in S3 Table. In the HDL frac-
tion and compared to baseline, significant increases in Apo A-I (p = 0.027; p = 0.021; p = 0.006,
for VOO, FVOO, and FVOOT respectively), Apo A-II (p = 0.029; p = 0.019; p = 0.004, for
VOO, FVOO, and FVOOT respectively), total protein (p = 0.073; p = 0.045; p = 0.037, for
VOO, FVOO, and FVOOT respectively), total cholesterol (p = 0.033; p = 0.037; p = 0.005, for
VOO, FVOO, and FVOOT respectively), phospholipids (p = 0.146; p = 0.021; p = 0.036, for
VOO, FVOO, and FVOOT respectively) and total mass (p = 0.050; p = 0.014; p = 0.016, for
VOO, FVOO, and FVOOT respectively) were observed after the three intervention periods.
However, as a consequence of the increment of the different parameters of the HDL particle
composition, the total mass of the HDL particle also increases and as a result, the composition
of HDL expressed as percentage of total mass remains stable and non-significant changes were
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observed. Compared to baseline, significant increases were also observed in plasma Apo A-I
and HDL-c after the three VOO intervention periods. However, no significant differences be-
tween the three VOO interventions, either in basal levels or in post interventions levels, were
observed suggesting that in the present study, the enrichment of VOO with PC might not affect
the ability of the VOO to increase different biochemical parameters and that the common ma-
trix of the three VOO produced the key changes. We did not observe a carryover effect during
the study.
HDL proteomic results
Identification of HDL-associated proteins. A total of 155 HDL-associated proteins were
initially identified by applying shotgun proteomics using Maldi and Orbitrap MS/MS to HDL
fractions isolated by ultracentrifugation. Data were subsequently screened to ensure protein
identification accuracy and 28 possible false-positives removed. The final list of HDL-associat-
ed proteins identified both at baseline and after interventions, was refined to 127 proteins (S4
Table). The majority (80/127) were consistent with well-established HDL-associated proteins
determined in at least 3 different MS studies [9] and 32 had been previously identified by at
least 1 MS study [9,17]. A total of 15 not previously referenced proteins were identified both at
baseline and after interventions, although they do not show any modulation during interven-
tions. These novel proteins are the following: Beta-Ala-His dipeptidase, BPI fold-containing
family B member 1, Carbonic anhydrase 6, CD209 antigen, CD44 antigen, CD5 antigen-like, Ig
heavy chain V-I region HG3, Ig lambda-1 chain C regions, Ig lambda-2 chain C regions, Ig
lambda-7 chain C region, Indian hedgehog protein, Integrin alpha-2, Integrin beta-1, Multi-
merin-2, and Thymidine phosphorylase. Six well-established HDL-associated proteins were
not detected: Apo O, Ceruloplasmin, Complement factor B, Inter alpha trypsin inhibitor 2,
Plasma Kallikerein and Plasminogen [9].
HDL quantitative analyses. Compared to baseline values (first visit), the HDL protein
cargoes of the differentially expressed proteins differed after the interventions according to the
VOO received. The complete list of the proteins differentially expressed after each VOO inter-
vention, and their principal biological functions, are shown in S5 Table. The proteins were
Table 1. Characteristics of the study participants at baseline.
Variable Sequence 1 (n = 11) Sequence 2 (n = 11) Sequence 3 (n = 11)
Gender (male/female) 5/6 7/4 7/4
Age, years 54.91 ± 12.57 55.27 ± 11.88 55.45 ± 7.84
Body weight, kg 74.75 ± 16.80 74.60 ± 18.49 84.45 ± 17.74
BMI, kg/m2 25.63 ± 3.68 26.31 ±5.25 27.85 ± 4.71
SBP, mm Hg 125.09 ± 18.70 128.27 ± 16.69 130.45 ± 17.93
DBP, mm Hg 68.09 ± 13.53 72.27 ± 9.31 71.91 ± 13.43
Glucose, mg/dL 88.55 ± 11.63 93.00 ± 13.33 90.91 ± 10.53
Total cholesterol, mg/dL 228.36 ± 42.70 231.91 ± 32.70 218.82 ± 31.21
LDL cholesterol, mg/dL 150.38 ± 32.33 152.08 ± 28.46 142.26 ± 25.72
HDL cholesterol, mg/dL 52.78 ±11.75 52.96 ±12.82 53.39 ± 9.55
Tryglicerides, mg/dL 94.00 (75.00; 149.00) 119.00 (95.00; 168.00) 117.00 (81.00; 126.00)
Values expressed as mean ± standard deviation (SD) or median (25th to 75th percentile). Sequence 1 = FVOO, FVOOT and VOO; Sequence 2 = FVOOT,
VOO and FVOO; Sequence 3 = VOO, FVOO and FVOOT. No signiﬁcant differences between groups were observed. To compare means or medians
among groups, ANOVA or Kruskal-Wallis test were performed, respectively; whereas χ2 and exact F-test, as appropriate, were computed to compare
proportions. Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure.
doi:10.1371/journal.pone.0129160.t001
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associated with a broad range of biological functions, principally cholesterol homeostasis, lipid
transport, acute-phase response, blood coagulation, immune response, protection against oxi-
dation, and proteolysis. The proteins differently modulated after VOO, FVOO, and FVOOT
interventions and associated with these main functions are represented in Fig 4. The overlap-
ping among interventions indicates that 15 proteins were commonly up- or down-regulated
after the three VOO interventions. These proteins were: Serum paraxonase/lactonase 3
(PON3), Apo A-II, Apo A-I, Apo D, Retinol binding protein 4 (RBP4), Heparin cofactor 2
(SERPIND1), zinc-alpha-2-glycoprotein (AZGP1), alpha-2-antiplasmin (SERPINF2), alpha-
2-HS-glycoprotein (AHSG), clusterin (CLU), alpha-2-macroglobulin (A2M), haptoglobin
(HP), alpha-1-acid glycoprotein (ORM1), Beta-Ala-His dipeptidase (CNDP1), and Aminopep-
tidase N (ANPEP). These 15 proteins that were observed to have the greatest expression modi-
fications were identified with both MS techniques, nano LC-MALDI MS/MS and nano
LC-ORBITRAP-ESI MS/MS. A protein-protein interaction network was generated for the 15
common, differentially expressed proteins using database and web-tool STRING 9.1 (S1 Fig).
The common up-regulated proteins were related to cholesterol homeostasis, blood coagulation
and protection against oxidation; the common down-regulated proteins were implicated in
acute-phase response, lipid transport, immune response, and proteolysis. All proteins except
for ANPEP and CNDP1, which are involved in proteolysis, appeared in the center of the func-
tional network intersection indicating their key role in protein interactions. The information of
these relevant proteins commonly regulated by the three VOO interventions was summarized
in Table 2.
In addition to these 15 commonly modulated proteins, other specific protein expression
changes were observed after each OO intervention. The stronger effects for each VOO were re-
lated to the following biological functions linked to atherosclerosis protection: transport, ho-
meostasis cholesterol, antioxidant protection, blood coagulation, innate immune response,
acute phase, and cellular adhesion. A stronger protein expression change was observed after
VOO intervention in the following 6 proteins: Apo C-I, Apo A-I, Cholesteryl ester transfer pro-
tein (CETP), PON3, histidine-rich glycoprotein (HRG), and Ig heavy chain V-I region HG3,
which were up-regulated while Ig lambda chain V-III region LOI was down-regulated. A stron-
ger effect after FVOO was observed on 2 protein expression changes, PON3 and platelet basic
protein (PPBP) which were up-regulated. Finally, a stronger up-expression change was noticed
after FVOOT in the following 7 proteins: Apo A-I, Apo A-IV, Apo C-II, Apo C-III, serum am-
yloid A protein 4 (SAA4), afamin (AFM) and integrin beta-3 (ITGB3).
Confirmation of the proteomic results by immunodetection methods. A panel of four
proteins identified by MS analysis with changes after the three interventions, two up-regulated
(Apo AI and Apo AII) and two down-regulated (Clusterin and Haptoglobin), were selected to
confirm the changes in the protein expression that were observed in the proteomic analysis.
These four proteins were quantified in the same 10 HDL pools used for proteomic analysis.
Apo A-I and Apo A-II increases observed by proteomics were confirmed by immunoturbidi-
metry. The fold-changes observed in Apo A-I and Apo A-II measured by immunodetection
were approximately 1.2 after the three VOO interventions compared to the basal value (Fig 5).
Moreover, the results obtained for clusterin and haptoglobin quantifications measured by
ELISA were also consistent with the decreases observed by proteomics with fold-changes of the
order of 0.9 (Fig 5). The fold-changes observed using immunodetection methods were in the
same way than those observed in proteomics analysis, even though they did not reach the same
fold-change values. We observed an increase tendency for Apo AI and Apo AII proteins and a
decrease tendency for Clusterin and Haptoglobin, in agreement with the MS findings, although
these tendencies did not achieve statistical significance probably due to the low sample size.
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Moreover, these results confirm that proteomics analyses are more sensitive to detect mini-
mum changes in HDL proteome.
Clustering and pathway analysis. IPA analysis was performed to reveal the canonical
pathways significantly affected (p<0.01) by OO phenols. The top 7 signaling pathways modi-
fied by the differentially expressed common proteins after all VOO interventions included:
LXR/RXR activation, acute phase response signaling, atherosclerosis signaling, IL-12 signaling
and production in macrophages, production of nitric oxide (NO) and reactive oxygen species
(ROS) in macrophages, Clathrin-mediated endocytosis signaling, and coagulation system (Fig
6). Our results showed that OO phenols tended to have a strong effect on LXR/RXR activation
(p = 2.39E-16; ratio = 0.071), followed by acute phase response signaling (p = 4.91E-15;
ratio = 0.052). The highest scoring associated network generated by IPA, and the differentially
expressed proteins common for all VOO interventions, are shown in Fig 7. The top scoring sig-
nificantly associated network (score = 30) included 12 focused proteins and several associated
genes, and was related to the following biological functions: lipid metabolism, small molecule
biochemistry, and molecular transport. The nuclear receptor subfamily 5, group A, member 2
(NR5A2) and interleukin 6 (IL-6) were associated genes appearing in this network and repre-
senting the significantly affected top upstream regulators (p<0.01). NR5A2, which is implicat-
ed in the canonical pathway of FXR/RXR activation and the biological process of cholesterol
Fig 4. Venn diagram showing intersections of proteins differentially expressed after VOO, FVOO, and
FVOOT interventions. Proteins are presented with their gene encode symbol. Red proteins: up-regulated;
green proteins: down-regulated. VOO: Virgin Olive Oil; FVOO: Functional Virgin Olive Oil enriched with its
own PCs; FVOOT: Functional Virgin Olive Oil enriched with its own PCs plus complementary phenols
from thyme.
doi:10.1371/journal.pone.0129160.g004
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Table 2. Relevant proteins commonly differentially regulated by the three VOO interventions.
Gene Symbol Protein Name Principal Biological Function VOO Fold
Change
FVOO Fold
Change
FVOOT Fold
Change
UP-REGULATED
APOA1 Apolipoprotein A-I Cholesterol homeostasis 1.69 1.37 1.60
PON3 Serum paraoxonase/
lactonase 3
Antioxidant protection 1.56 1.55 1.39
APOA2 Apolipoprotein A-II Cholesterol homeostasis 1.45 1.40 1.34
SERPIND Heparin cofactor 2 Blood coagulation 1.27 1.27 1.32
A2M Alpha-2-macroglobulin Blood coagulation 1.25 1.33 1.39
DOWN-REGULATED
HP Haptoglobin Acute-phase response 0.56 0.80 0.65
CLU Clusterin Complement pathway and innate
immune response
0.61 0.78 0.64
APOD Apolipoprotein D Lipid transport 0.61 0.71 0.68
AZGP1 Zinc-alpha-2-glycoprotein Immune response 0.69 0.75 0.63
ORM1 Alpha-1-acid glycoprotein 1 Acute-phase response 0.75 0.53 0.58
SERPINF2 Alpha-2-antiplasmin Acute-phase response 0.75 0.72 0.77
RBP4 Retinol-binding protein 4 Transport 0.78 0.78 0.77
ANPEP Aminopeptidase N Proteolysis 0.80 0.78 0.68
CNDP1 Beta-Ala-His dipeptidase Proteolysis 0.82 0.69 0.72
AHSG Alpha-2-HS-glycoprotein Acute-phase response 0.84 0.80 0.76
Fold change > 1.3 denotes proteins up-regulated while fold change < 0.8 denotes decrease protein expression after the VOO interventions relative to the
control-baseline. Gene symbol and principal biological function information were from UniProt database (http://www.uniprot.org/).
doi:10.1371/journal.pone.0129160.t002
Fig 5. Expression levels of Apo A-I, Apo A-II, Clusterin and Haptoglobin. Expression levels of Apo A-I
and A-II were measured by immunturbidimetry assays and clusterin and haptoglobin by ELISA assays in 10
HDL pools.
doi:10.1371/journal.pone.0129160.g005
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homeostasis, was predicted from our results to be activated. Likewise, IL-6, which is involved
in the acute phase response canonical pathway, was expected to be inhibited.
Discussion
The present study revealed that, in hypercholesterolemic subjects, a supplementary consump-
tion of 25 mL/day of raw VOO, FVOO, or FVOOT has an impact on the HDL proteome by
changing the expression of a number of proteins with biological functions related to the cardio-
protective function of the HDL particle. The greatest expression modifications were observed
in 15 of the 127 proteins identified in the HDL fractions which were commonly up- or down-
regulated after the three VOO interventions and might lead to a CVD protective HDL profile.
A finding that encouraged us to highlight the effect of the fatty acid composition and the role
of the PCs (lignans) of the common matrix of the three VOO tested on HDL remodeling.
Moreover, IPA analysis revealed that several signaling pathways related to CVD were affected
by OO PCs consumption. These data emphasize the key role of OO PCs in modifying pathways
and conferring cardioprotective properties. PCs of VOO could be capable of transcriptional
gene regulation inducing the down or up-regulation of proteins involved in functions related
to cardiovascular risk [18,19]. Farràs et al.[20] observed how PCs from OO could exert an in
vivo nutrigenomic effect on genes related to cholesterol efflux in humans. Moreover, PCs can
modulate enzyme activities which may represent relevant antioxidant mechanisms by which
dietary olive phenolic could have beneficial impact on cardiovascular health [21]. Phenol me-
tabolites from olive have been observed to be incorporated to HDL particles where they could
exert a local antioxidant protection and contribute to a functional enhancement of the HDL
particle [22]. In concordance with these results, we observed that thyme phenols were also in-
corporated to HDL after FVOOT intervention and that olive phenol metabolites were higher
after FVOO intervention compared to baseline and also to VOO. Furthermore, it has been re-
cently reported that hydroxytyrosol contribute to the protection of endothelium reticulum
(ER) stress which could cause unfolded or misfolded proteins and is considered as a new
emerging risk factor for CVD. This newly described effect of hydroxytyrosol on ER stress could
represent an alternative pathway through which olive oil phenols can modulate cell signaling
and could impact HDL proteome and functionality [23].
Fig 6. The top 7 signaling pathways that were significantly affected by the 15 common proteins
differentially expressed after all VOO interventions. Significance levels were assessed with Fisher’s
exact test (p<0.01). The pathways were ranked by p value. Blue bars indicate the negative log value (p-
value). The ratio was calculated as the number of molecules in a given pathway that meet cutoff criteria
divided by total number of molecules that make up that pathway.
doi:10.1371/journal.pone.0129160.g006
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To our knowledge, this is the first HDL proteomic study in humans that assesses the effects
of PCs on the HDL protein cargo.
Common effects of VOO interventions
Two well-known proteins related to cholesterol homeostasis, Apo A-I and Apo A-II, were sig-
nificantly augmented after the three VOO interventions. Both proteins participate in reverse
cholesterol transport and present anti-inflammatory and antioxidant properties [24,25]. The
increase in Apo A-I concurred with the results observed by Solà et al. [26] in high CVD risk
subjects after following a Mediterranean diet rich in VOO. PC could increase the expression
and secretion of Apo-AI by regulatory mechanisms involved in cholesterol biosynthesis and
metabolism [27]. The increment of Apo-AI observed could lead to a possible improvement of
HDL functionality by enhancing HDL cholesterol efflux via ATP-binding cassette transporter
Fig 7. Top scored associated network generated by IPA describing common differentially expressed
proteins after all VOO interventions. The top scoring significantly associated network was assessed with
Fisher’s exact test (p<0.01). Proteins were presented with their gene encode symbol. The proteins indicated
in red and green are those whose expression levels were significantly up- or down-regulated, respectively.
Proteins indicated in white are those available in the IPA database, but not detected as differentially
expressed in the present study. The shapes of the symbols denote the molecular class of proteins. Solid lines
indicate direct molecular interactions, whereas dashed lines indicate indirect molecular interactions.
doi:10.1371/journal.pone.0129160.g007
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A1 and HDL antioxidative properties, because Apo A-I is the major HDL component involved
in these activities [28].
Two proteins related to blood coagulation, SERPIND1 and A2M, were up-regulated after
the three VOO interventions thus increasing the cardioprotective activity of the HDL particle.
PON3, which is an antioxidant enzyme associated to HDL and with lactonase activity [29],
was up-regulated after all VOO interventions. This effect could be indicative of an improvement
in the oxidative status of the HDL particle promoted by the interventions. The effect of olive
and thyme PCs on the main activities of these antioxidant enzymes should be further studied.
AHSG, ORM1, SERPINF2, and HP are acute-phase response proteins which were down-
regulated after all VOO interventions. Acute-phase proteins are increased during inflammation
and could be used as inflammatory biomarkers related to CVD [30,31]. Our results are in con-
cordance with those of Santos-González et al. [32] who observed a decrease in acute-phase re-
sponse proteins after a VOO diet in rats.
Plasma Apo D and RBP4, which have been reported to be up-regulated during CVD devel-
opment [33,34], decreased after the three VOO interventions.
CLU, or Apo J, has been suggested to play a compensatory protective role by acting as an in-
flammatory modulator in myocardial infarction [35]. In the same way, AZGP1, has been ob-
served to be up-regulated to counteract metabolic stress situations in humans [36]. Both
proteins were down-regulated after all VOO interventions.
Stronger effects of each VOO intervention
In addition to the commonly modulated proteins, specific strong effects on the HDL protein
cargo were also observed after each intervention. For instance, after the intervention with
VOO, Apo C-I, Apo A-I, CETP, and PON3 were markedly up-regulated. Among these changes
the up-regulation of CETP is noteworthy. This protein facilitates the transport of cholesteryl
ester from HDL to Apo B-100 containing lipoproteins, and its plasma activity has been sug-
gested to be inhibited after a PC intervention [37]. To our knowledge, data concerning the ef-
fects of PCs on the expression and activity of CETP directly determined in HDL samples
instead of plasma samples are limited. Changes in some immunoglobulins after VOO interven-
tion were also reported. Immunoglobulins, which are secreted proteins related to innate im-
mune response, could be plasmatic contaminants [17]. Nevertheless, the possibility that the
HDL particle could act as a transporter of these proteins cannot be discarded and their role
should be further studied.
From all the marked expression changes observed after the FVOO intervention, we would
like to emphasize the up-regulation of the PON3.
We also highlight the strong up-regulation of Apo A-I, Apo A-IV, Apo C-II, and Apo C-III
among the changes observed after the FVOOT intervention. Apo A-IV is mainly related to
cholesterol homeostasis and oxidative protection, and has been associated with the cardiopro-
tective properties of the HDL particle [38]. Although Apo C-III protein is present in HDL, it is
also a major protein in VLDL. Chang et al. [39] showed positive associations between HDL-
Apo C-III and the presence of CVD, suggesting that high levels of Apo C-III in the HDL parti-
cle may represent a class of dysfunctional HDL. Such results are, however, still controversial
[39]. A redistribution of APOs between proatherogenic lipoproteins such as LDL to cardiopro-
tective HDL could have been possible during the FVOOT intervention.
Limitations and strengths
The pooling sample approach employed for the proteomic analysis, which was used to focalize
primarily on the whole protein response and also to optimize the associated research expenses,
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constitutes the limitation of our study. Because of the methodological process used, the results
of this work represent an exploratory analysis about the effect of a dietary intervention supple-
mented with a VOO or two different phenol enriched VOOs on the HDL proteome. However,
the analysis is not sufficiently robust to draw conclusions about which of the three VOO tested
has had the stronger effect on the HDL protein cargo. Future studies which analyze individual
samples instead of pooling samples should be done to better assess the difference in the impact
produced by the three types of VOO tested.
Moreover, HDL isolation is a key methodological point for proteomic analysis of HDL. Cur-
rently, the gold standard method for the HDL isolation is still under discussion and future at-
tempts will be targeted towards improving isolation procedures [40]. Whilst sequential
ultracentrifugation may alter HDL functionality, composition, and lead to a loss of lipid-poor
Apo A-I it continues to be the most commonly used procedure in these studies. To date, nearly
all proteomic studies of HDL have utilized density gradient ultracentrifugation based on meth-
ods for the isolation of HDL from human plasma [15]. However, the possibility exists that
non-HDL plasmatic contaminants could have been present in the isolated HDL fraction.
One of the strengths of this study is its randomized and crossover design, which permitted
the participants to ingest all VOO types. Moreover, the identification of the HDL-associated
proteins was done by with two different MS techniques, Orbitrap and Maldi, which provide re-
liability and robustness to our identification results. Furthermore, it is important to note the
novelty of the subject studied. The dietary modifications used in this study were very specific
considering that only the concentration and the source of PCs of VOO administrated changed
between interventions. The observed changes in the HDL proteome are smaller than those
found when comparing a healthy population with patients with acute coronary syndrome [16]
or with hemodialysis treatment [41]. However, our results are of great importance in the clini-
cal practice meaning that small dietary changes can cause a remodeling of the HDL protein
cargo improving the functionality of this particle.
Conclusions
The results of our study illustrate the potential of HDL proteomics to lead to new biomarkers
for CVD prevention. These HDL proteomics findings help to understand the improvement
of the HDL functionality by measuring the effectiveness of nutritional interventions in a
similar manner to pharmacological treatments as proposed by Birner-Gruenberger [40]. In
conclusion, consumption of VOO, or phenol-enriched VOOs, has an impact on the HDL
proteome in a cardioprotective mode that could enhance HDL functionality by up-regulating
proteins related to cholesterol homeostasis, protection against oxidation, and blood coagula-
tion while down-regulating proteins involved in acute-phase response, lipid transport,
and immune response. The common protein expression modifications reported after the
three VOOs indicate an important effect of the fatty acid and PC composition present in
the common matrix of these VOO on the HDL remodeling. Further studies are needed, how-
ever, in order to assess the specific effects of each VOO incorporating different phenolic
contents.
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